Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.
International Journal of Innovative Technologies in Social Science
A qualitative literature review summarizing mechanistic evidence and observational studies on SGLT2 inhibitors in neurodegenerative disease; raises questions about neuroprotective potential but reports no primary clinical trial data or effect sizes to support practice change.
A narrative review of mechanistic hypotheses and heterogeneous clinical evidence without a systematic synthesis, meta-analysis, or primary trial data; the source itself states more research is needed and does not quantify efficacy.
A narrative review proposing a structured preoperative assessment framework for functional psychosurgery in psychiatry, intended to guide clinical decision-making in specialized centers rather than report new empirical evidence.
Current Opinion in Clinical Nutrition & Metabolic Care
A narrative review synthesizing recent evidence on choline's role in metabolic health, identifying research gaps and future directions rather than reporting new primary data or definitive findings.
This is a commentary piece proposing a molecular mechanism (GABAB1R expression in dopamine neurons) linking DBS to antidepressant effects, without original clinical or experimental data of its own.
A single-centre observational study using invasive neurophysiology and structural connectomics to map psychiatric symptoms in PD; hypothesis-generating with mechanistic insight but requiring validation in independent cohorts and clinical outcome trials.
A narrative review synthesizing current knowledge on neuromodulation techniques (DBS and TMS) for anxiety disorders, summarizing FDA clearances, mechanistic insights, and treatment paradigm evolution rather than reporting new primary evidence.